Human antibodies against the second extracellular loop of -adrenoceptors (AAA) might increase the beating rate of isolated neonatal rat myocardiocytes. In a previous study, 56.7% of patients (pts) with "idiopathic" arrhythmias (IA) were positive for those antibodies. Aim of this study was to evaluate the functional (chronotropic) effect of AAA of pts with IA on rat myocardiocytes. Methods: The sera of 30 pts, 16 with Lown 2-4 ventricular arrhythmias (VA) and 14 with supraventricular arrhythmias (SVA), idiopathic or due to cardiomyopathy, all positive for AAA (ELISA method), were functionally tested for possible chronotropic effects on spontaneously beating rat myocardiocytes. Pharmacological (bisoprolol and atropine) effects on AAA functional activity were also evaluated. Results: The sera of 14/30 (46.7%) arrhythmic pts, 7 with SVA (5 paroxysmal atrial fibrillation, 1 atrial flutter and 1 focal atrial tachycardia) and 7 with VA (6 Lown4 and 1 Lown2) induced a positive chronotropic effect of rat myocardiocytes (mean heart rate increase: 27.77±6.36 SD, beats/min), up to 63.2% of the maximal effect of isoproterenol (10-5M). Such response was antagonised by 1-selective blocker bisoprolol (10-6M) in 8/14 pts (2 VA and 4 SVA). In 6/16 pts sera without chronotropic effect (3 of VA and 3 of SVA pts) tested in the presence of atropine (1M) to exclude inhibitory effects mediated by muscarinic receptors stimulation, no change was found. In conclusion, 46.7% of the AAA purified from seropositive pts with IA were functionally active, inducing tachycardia of rat myocardiocytes. This suggests a possible arrhythmogenic role of AAA, either by inducing a catecholamine-like automaticity enhancement by 1-adrenoceptor stimulation (8 cases, blocked by bisoprolol), or affecting other molecular targets (6 cases unaffected by bisoprolol).
Ruggieri, M., Wallukat, G., Hoebeke, J., Fenici, P., Giorgi, A., Brisinda, D., Fenici, R., Anti Beta-Adrenoceptors Autoantibodies and idiopathic arrhythmias: functional effect, Abstract de <<XX Congress of the European Society of cardiology>>, (Vienna, 22-26 August 1998 ), <<EUROPEAN HEART JOURNAL>>, 1998; 1998 (19): 79-79 [http://hdl.handle.net/10807/18071]
Anti Beta-Adrenoceptors Autoantibodies and idiopathic arrhythmias: functional effect
Fenici, Peter;Brisinda, Donatella;Fenici, Riccardo
1998
Abstract
Human antibodies against the second extracellular loop of -adrenoceptors (AAA) might increase the beating rate of isolated neonatal rat myocardiocytes. In a previous study, 56.7% of patients (pts) with "idiopathic" arrhythmias (IA) were positive for those antibodies. Aim of this study was to evaluate the functional (chronotropic) effect of AAA of pts with IA on rat myocardiocytes. Methods: The sera of 30 pts, 16 with Lown 2-4 ventricular arrhythmias (VA) and 14 with supraventricular arrhythmias (SVA), idiopathic or due to cardiomyopathy, all positive for AAA (ELISA method), were functionally tested for possible chronotropic effects on spontaneously beating rat myocardiocytes. Pharmacological (bisoprolol and atropine) effects on AAA functional activity were also evaluated. Results: The sera of 14/30 (46.7%) arrhythmic pts, 7 with SVA (5 paroxysmal atrial fibrillation, 1 atrial flutter and 1 focal atrial tachycardia) and 7 with VA (6 Lown4 and 1 Lown2) induced a positive chronotropic effect of rat myocardiocytes (mean heart rate increase: 27.77±6.36 SD, beats/min), up to 63.2% of the maximal effect of isoproterenol (10-5M). Such response was antagonised by 1-selective blocker bisoprolol (10-6M) in 8/14 pts (2 VA and 4 SVA). In 6/16 pts sera without chronotropic effect (3 of VA and 3 of SVA pts) tested in the presence of atropine (1M) to exclude inhibitory effects mediated by muscarinic receptors stimulation, no change was found. In conclusion, 46.7% of the AAA purified from seropositive pts with IA were functionally active, inducing tachycardia of rat myocardiocytes. This suggests a possible arrhythmogenic role of AAA, either by inducing a catecholamine-like automaticity enhancement by 1-adrenoceptor stimulation (8 cases, blocked by bisoprolol), or affecting other molecular targets (6 cases unaffected by bisoprolol).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.